Published on 10 Mar 2023 on Zacks via Yahoo Finance
Pliant Therapeutics, Inc. (PLRX) came out with a quarterly loss of $0.72 per share versus the Zacks Consensus Estimate of a loss of $0.70. This compares to loss of $0.68 per share a year ago. These figures are adjusted for non-recurring items.
This quarterly report represents an earnings surprise of -2.86%. A quarter ago, it was expected that this company would post a loss of $0.74 per share when it actually produced a loss of $0.65, delivering a surprise of 12.16%.